Aging Table 4 Musculoskeletal System
Author Year; Country | Methods | Outcome |
|---|---|---|
Kivimaki & Ahoniemi 2008; Finland Downs & Black = 23 Cross-sectional with AB control N SCI = 120 N controls = 103 | Population: 120 SCI subjects at least 3 months post-injury (54 paraplegic, 66 tetraplegic, age 18-65), and 103 AB control subjects Methodology: Comparison of shoulders Outcome Measures: Ultrasonography; on the acromioclavicular joint, the supraspinatus tendon, bicipitus longus tendon and the tendon sheath, posterior glenohumeral joing space; performance-corrected Wheelchair User's Shoulder Pain Index (PC-WUSPI) |
|
Australia Downs & Black =18 Longitudinal N=73 | Population: 60 males and 13 females; mean age at baseline 40 (21 – 81 yrs); mean time post-injury at baseline < 6 mos Methodology: Assessed the prevalence, onset, and severity of pain at less than 1 YPI and at 5 YPI Outcome Measures: Pain intensity via numeric scale; Psychological distress; Von Korff chronic pain disability to assess pain interference on daily activities; assessed at less than 1 YPI and again at 5 YPI |
|
Switzerland Downs & Black = 16 Longitudinal N=39 | Population: 39 SCI subjects, 28 paraplegic, 11 tetraplegic, ASIA A and B, mean age 42.0±13.4 yrs (range 21-64), 0.9-34 YPI (mean 12.0±10.8) Methodology: To evaluate changes in bone mineral density (BMD) of distal epiphyses and midshafts of femur, tibia Outcome Measures: Bone measures by pQCT in the radius of the non-dominant arm and the tibia and femur of the opposite leg at baseline, 15 months, and 30 months. |
|
Akbar et al. 2010; Germany Downs & Black = 15 Cross-sectional with AB controls SCI N = 100 (N controls = 100) | Population: 72 males and 28 females with paraplegia; SCI level T2-L3; mean age 52 ±9 yrs (range 29-70); mean YPI 33.7 (range 29-48 yrs); wheel chair dependent for minimum 30years; body mass index <40; no active shoulder infection; no previous upper extremity surgery; 100 age and gender matched AB controls
Methodology: Comparison shoulder function, pain and prevalence of rotator cuff tears between individuals with paraplegia with at least 30 years experience with using a wheelchair and an age and sex matched control group. Outcome Measures: MRI, shoulder function (Constant score), pain (visual analog scale).
|
|
Jensen et al. 2005; USADowns & Black =14 N = 147 Longitudinal | Population: 110 males and 37 females; mean age at follow-up 48.8 + 13.0 (21 – 88 yrs); mean YPI at follow-up 16.6 + 10.4 (3.2 – 57.4 yrs). Methodology: Examine the change in the prevalence and intensity of pain over time Outcome Measures: Brief Pain Inventory Interference scale; Bodily Pain scale; SF-36; Mental Health scale (range of 2-6 years between assessments) |
|
Frey-Rindova et al. 2000; Switzerland Downs & Black = 14 Longitudinal N = 29 | Population: 27 males and 2 females; age range 19 – 57 yrs. Methodology: To evaluate changes in Trabecular and cortical bone mineral density (BMD) Outcome Measures: Trabecular and cortical BMD, evaluated at 1, 6, 12, and 24 months past injury |
|
Switzerland Downs & Black = 14 Cross-sectional with AB controls N SCI = 89 N controls = 21 | Population: All males; mean age 41.5 + 14.2 (range 10-65 yrs); mean YPI 29.3 + 12.5 (range 2 mos-50 yrs); age and gender matched AB controls
Methodology: Comparison of bone mineral density of distal epiphyses and midshafts of femur, tibia, and radius Outcome Measures: BMD of distal epiphyses and midshafts of femur, tibia, and radius
|
|
Szoller et al. 1997b; USA Downs & Black = 13 Cross-sectional with AB controls N SCI = 263 N controls = 92 | Population: All males with SCI; mean age 48.8 + 1.3 (20 – 78 yrs); YPI range 0.8 to 53 yrs; age and gender matched AB controls Methodology: Comparison of bone mineral density (BMD) of the lumbar spine, femoral neck, Ward’s triangle, and the greater trochanter with AB controls Outcome Measures: BMD of the lumbar spine, femoral neck, Ward’s triangle |
|
USA Downs & Black = 13 Cross-sectional with AB controls N SCI = 50 N controls = 50 | Population: 50 able-bodied (AB) male controls and 50 males with paraplegia (T4 complete, 3-10 YPI), ages 20-65 yrs, age-, height-, and weight-matched. Methodology: Both groups were stratified according to age and compared. Outcome Measures: Strength, endurance, blood pressure and heart rate responses to fatiguing isometric exercise. |
|
de Bruin et al. 2000; Switzerland Downs & Black = 13 | Population: All males; mean age 32.4 + 9 (23-50 yrs) at follow-up Methodology: Monitoring changes in structural and geometric properties of the tibia and cortical bone Outcome Measures: Structual and geometric properties of the tibia and cortical bone, assessed at 5 weeks post-injury and again at approx. 2 YPI |
|
Garland et al. 2004; USA Downs & Black = 13 Longitudinal N = 6 | Population: 6 patients (1 female) with complete paraplegia and 1 with L1 incomplete paraplegia ages 24.4 + 3.9. Methodology:Bone mineral density (BMD) measured from proximal to distal sites assessed at 33.5 and 523 days post-injury. Outcome Measures:Dual-energy X-ray absorptiometry (DXA) and ultrasound (US).
|
|
Rittweger et al. 2010; Germany Downs & Black = 12 Cross-sectional with AB controls N SCI = 9 N controls = 9 | Population: 9 males with SCI (lesions between L1 and T5, 8 motor complete, 1 motor incomplete); mean YPI 21.4 (range 9-32); mean age 21.4 years (range 17-35 years); 9 age-height-weight matched AB controls Methodology: Comparison of the total mineral bone content in the tibia of SCI participants and AB controls. Outcome Measures: Serial tomographic scans performed sequentially in steps of 5% of the tibia length from distal to proximal. |
|
de Bruin et al. 2005; Switzerland Downs & Black = 12 Longitudinal N =10 | Population: 9 males and 1 female; mean age 40.9 + 19.7 (range 19-81 yrs) at follow-up Methodology: Comparison of trabecular and compact bone mineral density (BMD) of tibia and radius at 5 weeks post-injury and at approx. 3.5 YPI Outcome Measures: Trabecular and compact BMD |
|
Dudley-Javoroski & Shields 2010; USA Downs & Black = 12 Mixed Cross-sectional/longitudinal N SCI = 15 N control = 10
| Population: 15 individuals (14 males and 1 female) with SCI; age at SCI (range 18-49 yrs); 10 age and stature (femur length) matched AB controls (9 males and 1 female) Methodology: Comparison of BMD of the femur metaphysis (12% of length from distal end) by using pQCT imaging over two years. Outcome Measures: Bone mineral density (BMD) |
|
Greece Downs & Black = 12 Cross-sectional comparative study N SCI = 31 N controls = 30 | Population: 31 males with complete paraplegia (AIS A) ; >1.5 years post injury; 16 in Subgroup A (T4-T7, mean age 32.88±15.6 yrs) and 15 in Subgroup B (T8-T12, mean age 39.47±13.81 yrs); 30 age-height-weight-gender matched AB controls; mean age 33.9±3.81 yrs Methodology: Comparison of the influence of positive (spasticity, standing-therapeutic walking), and negative factors (duration of paralysis) on bone structures between groups using pQCT measurement Outcome Measures: Total, trabecular and cortical bone mineral density (BMD), cortical thickness at distal tibial epiphysis and tibial diaphysis, Stress Strain Index at 14% (SSI2) and 38% (SSI3) of tibial diaphysis. |
|
Canada Downs & Black = 12 Cross-sectional with AB controls N SCI = 52 N controls = 52 | Population: 52 males with complete paraplegia (T2-L5, mean age 44 yrs, mean 17 years post-injury) and 52 age- and activity level-matched able-bodied (AB) males. Methodology: Bilateral upper limb physical functions were compared between the paraplegic and able bodied groups. Outcome Measures: Concentric isokinetic average torque for shoulder, elbow flexion/extension, shoulder adduction and eccentric shoulder adduction, grip strength, shoulder and elbow active ROM, upper limb pain. |
|
Belgium Downs & Black = 11 Longitudinal N SCI = 31 | Population: 31 patients (24 males) with T2 – L3 paraplegia ages 32.5 (17.5 to 65.5 years). Methodology:Total body and regional bone mineral content (BMC) and soft-tissue composition assessed at 5, 10, 20, 30, 40, and 50 weeks post-injury. Outcome Measures:Dual-energy X-ray absorptiometry (DXA) and soft tissue phantom. |
|
USA Downs & Black = 11 Cross-sectional with AB controls N SCI = 246 N controls = 188 | Population: 239 males and 7 females; age range 21-78 yrs; YPI range 0.1-51 yrs Methodology: Comparison of bone mineral density (BMD) throughout the femur and geometric properties at the femoral midshaft Outcome Measures: BMD in various femoral regions |
|
USA Downs & Black = 11 Cross-sectional with AB controls N SCI = 31 N controls = 17 | Population: 31 women with complete SCI mean age 43.9 + 19.7 and mean 16.9 + 7.7 years post-injury; 17 able-bodied age-matched women mean age 44.7 + 2.5. Methodology:Bone mineral density (BMD) measured from lumbar spine, hip, and knee. Outcome Measures:Dual-energy X-ray absorptiometry (DXA). |
|
Greece Downs & Black = 11 Cross-sectional with AB controls N SCI = 57 N controls = 92 | Population: 33 males and 24 females with paraplegia, mean age 37.8 (range 21 – 66 yrs); YPI range 6 months - 27 yrs; age and gender-matched AB controls Methodology: Comparison of bone mineral density (BMD) of the proximal and distal forearm, the femoral neck, the greater trochanter, and Ward’s triangle Outcome Measures: BMD of the proximal and distal forearm, the femoral neck, the greater trochanter, and Ward’s triangle |
|
USA Downs & Black = 11 Cross-sectional with AB controls N SCI = 135 N controls = 69 | Population: Able-bodied (AB) individuals ages 24-76, mean 51.1 ±1.7 years; SCI patients’ ages 20-78 years, mean 48.8±1.3 years. Methodology: Both groups were stratified according to age and compared; SCI patients were grouped according to neurologic group within the various age categories. Outcome Measures: Bone mineral density (BMD) in the lumbar spine, femoral neck, Ward’s triangle, and the greater trochanter. |
|
USA Downs & Black =11 Cross-sectional with AB controls N SCI = 176 N controls = 62 | Population: All males with SCI; mean age 41.2 (20 – 59 yrs); YPI range 0.8 to 34 yrs. Methodology: Comparison of bone mineral density (BMD), serum levels of calcium, calcitonin, biochemical markers of bone formation, and parathyroid hormone (PTH) Outcome Measures: BMD of the lumbar spine, femoral neck, Ward’s triangle, and the greater trochanter, serum levels of calcium, calcitonin, biochemical markers of bone formation, and parathyroid hormone (PTH) |
|
Norway Downs & Black =11 Cross-sectional with AB controls N SCI = 19 N controls = 19 | Population: All males with SCI; median age at injury 20 (range 15 – 64 yrs); median YPI 4 yrs (range 7 months – 33 yrs); age and gender matched AB controls Methodology: Comparison of bone mineral density (BMD) of lower and upper extremities, and of biochemical and bone markers Outcome Measures: BMD of lower and upper extremities, and of biochemical and bone markers |
|
USA Downs & Black = 11 Cross-sectional with AB control N SCI = 8 N controls = 8 | Population: Able-bodied (AB) twins of 8 males with SCI with complete paraplegia ages 40.4 + 10, 16 + 9 years post-injury. Methodology:Bone mineral content (BMC) and density (BMD) for total and regional skeletal bone mass. Outcome Measures: Dual-energy X-ray absorptiometry (DXA). |
|
USA Downs & Black = 11 Cross-sectional with AB controls N SCI = 19 N controls = 17 | Population: 19 women with complete SCI; mean age of premenopausal (< 30 yrs) 23.0 + 2.55 yrs; mean YPI 5.6 + 2.33 yrs, mean age of premenopausal (>35 yrs) 42.6 + 4.66 yrs; mean YPI 12.2 + 8.14 yrs; mean age of post-menopausal 54.5 + 7.7 yrs; mean YPI 14.17 + 11.9 yrs; 17 age and gender matched AB controls Methodology: Comparison of the trabecular bone of the knee Outcome Measures: Trabecular bone thickness, trabecular bone volume |
|
USA Downs & Black =10 Longitudinal N = 45 | Population: All males with complete SCI; mean age 28.1 + 0.78 yrs – 25; mean days post-injury 114.1 + 8.6 Methodology: Assessment of TBM and BMD at different times post-injury Outcome Measures: Total bone mass (TBM), and bone mineral density (BMD), assessed at 114.1+8.6 days post-injury and again at 468.9+21 days post-injury |
|
Canada Downs & Black = 10 Cross-sectional with AB controls N SCI = 2 N controls = 2 | Population: Both females; Twin pair 1 (TP1) – mean age 32 yrs; mean YPI 7 yrs; C7 complete tetraplegia; Twin pair 2 (TP2) – mean age 47 yrs; mean YPI 20 yrs; T8 paraplegia. Methodology: Comparison of bone mineral density (BMD), bone geometry, and muscle cross-sectional area (CSA) with monozygotic twin. Outcome Measures: BMD, bone geometry, and muscle CSA |
|
France Downs & Black =10 Cross-sectional with AB controls N SCI = 31 N controls = 31 | Population: All males with SCI; mean age 36 + 12.3 (range 18 – 60 yrs); mean YPI 6 (6 months – 19 yrs); age and gender matched AB controls Methodology: Comparison of supra- and sublesional bone mineral density (BMD) and bone mineral content (BMC), and of blood and urine samples that included phosphocalcic parameters with determination of urinary hydroxyproline and deoxypyridinoline Outcome Measures: supra- and sublesional BMD and BMC, blood and urinary phosphate level, and urinary levels of calcium, hydroxyproline and deoxypyridinoline |
|
USA Downs & Black =10 Cross-sectional with AB controls N SCI = 100 N controls = 50 | Population: All males with SCI, mean age 51 + 14 yrs; mean YPI 20 + 13 (range 1 – 48 yrs); 50 age and gender matched controls Methodology: Comparison of serum calcium (Ca), phosphorus (PO4), albumin, alkaline phosphatase (Alk P), and parathyroid hormone (PTH) with serum 25-hydroxyvitamin D [25(OH)D] Outcome Measures: serum levels of calcium (Ca), phosphorus (PO4), albumin, alkaline phosphatase (Alk P), and parathyroid hormone (PTH) with serum 25-hydroxyvitamin D [25(OH)D] |
|
United Kingdom Downs & Black = 9 Cross-sectional with AB controls N SCI = 31 AB reference population | Population: 19 males and 12 females with SCI, age range 19 – 60 yrs; mean YPI 5.87 + 10.21 (range 5 wks – 36 yrs); age and gender matched AB reference population Methodology: Comparison of bone mineral density (BMD) of right heal, lumbar spine, and proximal femur region (femoral neck, Ward’s triangle, trochanteric and inter-trochanteric), and of bonestructure (stiffness) Outcome Measures: BMD of right heel, lumbar spine, and proximal femur region (femoral neck, Ward’s triangle, trochanteric and inter-trochanteric); bone structure |
|
USA Downs & Black =9 Cross-sectional with AB controls N SCI = 40 N controls = 14 | Population: All males with SCI; age range 25 – 69 yrs; YPI range 3 – 50 yrs Methodology: Comparison of serum levels of parathormone (PTH), calcitonin, vitamin D (calcitriol), 25 hydroxy (OH) vitamin D, 1,25 (OH)2 , ionized calcium (Ca++), and phosphorous Outcome Measures: serum levels of parathormone (PTH), calcitonin, vitamin D (calcitriol), 25 hydroxy (OH) vitamin D, 1,25 (OH)2, ionized calcium (Ca++), and phosphorous |
|
Australia Downs & Black = 8 Cross-sectional with AB controls N SCI = 30 N controls = 30 | Population: All males with tetraplegia, divded into four groups (age > 50 yrs & YPI< 5 yrs; age < 40 yrs & YPI < 5yrs; age > 50 yrs & YPI > 15 yrs; age < 40 yrs & YPI > 15 yrs); age and gender matched AB controls Methodology: Comparison of posture Outcome Measures: Poster, through photography of bony landmarks |
|
Israel Downs & Black = 7 Longitudinal N = 9 | Population: 9 C3-T11 paraparetic patients; Age at enrollment: mean 37.5 years, range 24-67. Able-bodied controls from another study. Methodology: Lumbar spine dimensions assessed twice over 10 year interval. Outcome Measures: Lumbar anteroposterior (AP) radiographs. |
|
Lal 1998; USA Downs & Black =7 Longitudinal N = 53 | Population: 35 males and 18 females; mean age 37 (range 19-81 yrs) at baseline Methodology: Monitoring incidence of degenerative shoulder changes Outcome Measures: Incidence of degenerative shoulder changes, accessed through X-ray at baseline and every 2 years after until 5-15 YPI |
|
Denmark Downs & Black = 7 Longitudinal N SCI = 8 | Population: 8 patients (6 male) with complete paraplegia and 1 with L1 incomplete paraplegia ages 24.4 + 3.9 Methodology:Bone mineral content (BMC) from lumbar spine, femoral neck and shaft, proximal tibia and distal forearm assessed at 43 days, and 5-13 up to 31-53 months post -injury. Outcome Measures:Dual photon absorptiometry (DPA). |
|